These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance. Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393 [TBL] [Abstract][Full Text] [Related]
4. A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens. Berbers GA; van de Wetering MS; van Gageldonk PG; Schellekens JF; Versteegh FG; Teunis PF Vaccine; 2013 Aug; 31(36):3732-8. PubMed ID: 23742995 [TBL] [Abstract][Full Text] [Related]
5. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination. Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499 [TBL] [Abstract][Full Text] [Related]
6. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. Dalby T; Petersen JW; Harboe ZB; Krogfelt KA J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003 [TBL] [Abstract][Full Text] [Related]
7. Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo. Xing DK; Canthaboo C; Corbel MJ Vaccine; 2000 Apr; 18(20):2110-9. PubMed ID: 10715525 [TBL] [Abstract][Full Text] [Related]
8. Age-related differences in antibody avidities to pertussis toxin and filamentous hemagglutinin in a healthy Japanese population. Fumimoto R; Otsuka N; Sunagawa T; Tanaka-Taya K; Kamiya H; Kamachi K Vaccine; 2019 Apr; 37(18):2463-2469. PubMed ID: 30930008 [TBL] [Abstract][Full Text] [Related]
9. A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults. Leroux-Roels G; Lattanzi M; Solis CD; Contorni M; Costantini M; Moraschini L; Bardelli M; Bertholet S; Borgogni E; Buricchi F; Cantisani R; Faenzi E; Finco O; Leuzzi R; Pizza M; Rosa D; Schiavetti F; Seubert A; Spensieri F; Volpini G; Zedda L; Giudice GD; Galgani I Hum Vaccin Immunother; 2018 Jan; 14(1):45-58. PubMed ID: 29172945 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice. Boehm DT; Hall JM; Wong TY; DiVenere AM; Sen-Kilic E; Bevere JR; Bradford SD; Blackwood CB; Elkins CM; DeRoos KA; Gray MC; Cooper CG; Varney ME; Maynard JA; Hewlett EL; Barbier M; Damron FH Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30012638 [No Abstract] [Full Text] [Related]
12. [Seroprevalence of pertussis toxin antibody in Manisa province of Turkey, after six years implementation of acellular pertussis vaccine]. Özbek ÖA; Öktem İMA; Hekimoğlu CH; Sekreter Ö; Emek M; Atasoylu G; Açıkgöz A; Demirpençe N; Ceylan A; Baykal ES; Ünal B Mikrobiyol Bul; 2018 Apr; 52(2):180-189. PubMed ID: 29933735 [TBL] [Abstract][Full Text] [Related]
13. Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization. Acquaye-Seedah E; Reczek EE; Russell HH; DiVenere AM; Sandman SO; Collins JH; Stein CA; Whitehead TA; Maynard JA Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29581192 [TBL] [Abstract][Full Text] [Related]
14. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Cherry JD; Gornbein J; Heininger U; Stehr K Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041 [TBL] [Abstract][Full Text] [Related]
15. Antibody Specificity Following a Recent Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T Front Immunol; 2019; 10():1364. PubMed ID: 31275314 [No Abstract] [Full Text] [Related]
16. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247 [TBL] [Abstract][Full Text] [Related]
17. Immunization with whole cell but not acellular pertussis vaccines primes CD4 T Wilk MM; Borkner L; Misiak A; Curham L; Allen AC; Mills KHG Emerg Microbes Infect; 2019; 8(1):169-185. PubMed ID: 30866771 [TBL] [Abstract][Full Text] [Related]
18. Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age. Huang LM; Lee CY; Lin TY; Chen JM; Lee PI; Hsu CY Vaccine; 1996 Jun; 14(9):916-22. PubMed ID: 8843635 [TBL] [Abstract][Full Text] [Related]
19. Investigating pertussis toxin and its impact on vaccination. Coutte L; Locht C Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial. Wood N; Nolan T; Marshall H; Richmond P; Gibbs E; Perrett K; McIntyre P JAMA Pediatr; 2018 Nov; 172(11):1045-1052. PubMed ID: 30208475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]